Biogen has returned its Aduhelm rights to Neurimmune, the company that initially developed the antibody Alzheimer's disease drug. But Biogen isn't abandoning Alzheimer's, and its pipeline includes drugs that take other approaches to the neurodegenerative disorder.
World-renowned cardiologist Dr. Henry Ting, who is currently the Senior Vice President, Chief Health & Wellness Officer, Delta Air Lines, and Adjunct Professor of Medicine, Emory University, and Professor Emeritus, Mayo Clinic. See him May 21-22 in Chicago. You can still save with the super early pricing until February 16th.
To succeed in ACO Reach, groups need to accurately identify the social determinants of health (SDoH) barriers affecting their patient population and determine which barriers could be addressed effectively. Some technology can accurately note specific SDoH risk factors facing a given patient and offer targeted intervention recommendations based on that patient's unique SDoH risk factors.
Being Health, a startup that launched last week, offers a care team that includes psychiatrists, psychotherapists, nurse anesthetists, functional medicine physicians, nutritionists, acupuncturists and care advocates. It serves patients both virtually and in person.
Point-of-care lung ultrasound – also known as lung POCUS – is a safer, more reliable alternative to X-ray in diagnosing pneumonia that provides information quickly. Yet it's not widely considered the standard of care.
We and our collective organizations' providers have treated 10,000's of Americans, who suffer from obesity and/or Type 2 diabetes with GLP-1 drugs. And we believe we have important observations to share.
This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities.
No comments:
Post a Comment